This never tests out for gliadin antibodies
Aging 2 , 526535 (2022)
published in 2021, chronic hypoparathyroidism treated with conventional therapy is associated with higher rates of renal complications compared to the general population, including nephrolithiasis (up to 36%), nephrocalcinosis (up to 38%), and chronic kidney disease (up to 41%)
Multiple studies have observed that people with metabolic challenges tend to have significantly lower levels of Akkermansia in their gut microbiome,* and the landmark human clinical trial on pasteurized MucT a randomized, double-blind, placebo-controlled study demonstrated that supplementation improved insulin sensitivity, reduced insulinemia, and lowered plasma total cholesterol compared to placebo over three months.* The MucT strain is also the only Akkermansia to receive EFSA (European Food Safety Authority) novel food approval, based on its extensive safety and efficacy data.* Convenience Both products are one capsule daily
Theyre not often covered by insurance and can therefore be extremely pricey
Legality and safety vary: a generic produced in India under that country's legal framework is not FDA-approved for import into the U.S., and purchasing it exposes patients to customs seizure risk and product quality uncertainty